Perioperative management of patients taking direct oral anticoagulants: a review
JD Douketis, AC Spyropoulos - JAMA, 2024 - jamanetwork.com
Importance Direct oral anticoagulants (DOACs), comprising apixaban, rivaroxaban,
edoxaban, and dabigatran, are commonly used medications to treat patients with atrial …
edoxaban, and dabigatran, are commonly used medications to treat patients with atrial …
Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios
F Lucà, F Oliva, MG Abrignani, SA Di Fusco… - Journal of Clinical …, 2023 - mdpi.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
Continuation versus Interruption of Oral Anticoagulation during TAVI
DJ van Ginkel, WL Bor, HM Aarts… - … England Journal of …, 2024 - Mass Medical Soc
Background One third of patients undergoing transcatheter aortic-valve implantation (TAVI)
have an indication for oral anticoagulation owing to concomitant diseases. Interruption of …
have an indication for oral anticoagulation owing to concomitant diseases. Interruption of …
Peptide‐Based Organic‐Inorganic Hybrid Self‐Assemblies for Ultrasensitive and Visual Detection of Heparin
F Fan, XM Chen, J Lin, M Lin, L Li, Y Gu… - Advanced Functional …, 2024 - Wiley Online Library
Accurate point‐of‐care testing (POC) of low molecular weight heparin (LMWH) can
efficiently promote its rational use in the prevention and treatment of thromboembolic …
efficiently promote its rational use in the prevention and treatment of thromboembolic …
[HTML][HTML] Perioperative management of antiplatelet therapy: a systematic review and meta-analysis
Objective To summarize the available evidence about the perioperative management of
patients who are receiving long-term antiplatelet therapy and require elective …
patients who are receiving long-term antiplatelet therapy and require elective …
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American …
Writing Committee Members, A Thompson… - Journal of the American …, 2024 - jacc.org
Abstract Aim The “2024 aha/acc/acs/asnc/hrs/sca/scct/scmr/svm Guideline for Perioperative
Cardiovascular Management for Noncardiac Surgery” provides recommendations to guide …
Cardiovascular Management for Noncardiac Surgery” provides recommendations to guide …
Prevention of perioperative stroke in patients undergoing non-cardiac surgery
About 300 million adults undergo non-cardiac surgery annually. Although, in this setting, the
incidence of perioperative stroke is low, the absolute number of patients experiencing a …
incidence of perioperative stroke is low, the absolute number of patients experiencing a …
Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus
In the United States, an estimated 79,000 cases and 13,920 deaths will be attributable to
kidney cancer in 2022. 1 Most kidney cancers are primary renal cell carcinomas (RCC) of …
kidney cancer in 2022. 1 Most kidney cancers are primary renal cell carcinomas (RCC) of …
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding
D Cao, N Amabile, M Chiarito, VT Lee… - European Heart …, 2023 - academic.oup.com
Remarkable progress has been made in the pharmacological management of patients with
cardiovascular disease, including the frequent use of antithrombotic agents. Nonetheless …
cardiovascular disease, including the frequent use of antithrombotic agents. Nonetheless …
Venous thromboembolism prophylaxis in major orthopedic surgeries and factor XIa inhibitors
A Jones, RA Al-Horani - Medical Sciences, 2023 - mdpi.com
Venous thromboembolism (VTE), comprising pulmonary embolism (PE) and deep vein
thrombosis (DVT), poses a significant risk during and after hospitalization, particularly for …
thrombosis (DVT), poses a significant risk during and after hospitalization, particularly for …